Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.

This webinar will review how kinetic characterization of biological interactions can guide the selection of best-in-class detector molecules to enhance lateral flow diagnostics and outline the benefits of characterizing and selecting your lateral flow antibodies using SPR technology.

Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.

Raw materials identification (RMID) is a crucial regulatory step required before drug manufacturing. Raman spectroscopy is well-suited to making the process simpler, yet some spectrometers are challenged by light-blocking containers or struggle to reach compliance standards.

Cell and gene therapies harness the power of cells or genetic material to treat, cure or prevent diseases. These cutting-edge therapeutics have the potential to revolutionize medical treatments, especially for conditions that were previously thought to be incurable, including genetic disorders, cancer and degenerative conditions.

Dr. Yuan Liu from Indiana University will be joining Technology Networks to provide a comprehensive overview of this promising field, paving the way for potential therapeutics.